文献速递生殖医学

来曲唑促排卵、自然周期或程序化周期行冻融胚胎移植后的妊娠结局

Pregnancy outcomes after frozen-thawed embryo transfer using letrozole ovulation induction, natural, or programmed cycles.
PubMed 文献 · Fertil Steril · 2022-07-19

一项美国单中心回顾性队列研究纳入2015年1月至2021年7月共3148个冻融胚胎移植周期,比较来曲唑促排卵、自然周期与程序化周期的妊娠结局。来曲唑组和自然周期组的持续妊娠率/活产率优于程序化周期,自然周期组临床流产率低于程序化周期组。

要点

  • 来曲唑周期持续妊娠率/活产率高于程序化周期(aRR 1.11,95%CI 1.02-1.21)。
  • 自然周期临床流产率低于程序化周期(aRR 0.62,95%CI 0.46-0.84)。
  • 排卵正常女性中来曲唑周期活产率高于程序化周期(aRR 1.16,95%CI 1.05-1.28)。

核心结论

  • 来曲唑和自然周期冻融胚胎移植的临床结局优于程序化周期。

研究设计与样本

  • 回顾性队列研究,纳入2015年1月至2021年7月单大学附属不孕症诊所的3148个冻融胚胎移植周期。
  • 纳入患者年龄≤45岁,移植自体卵母细胞来源的囊胚。

主要发现

  • 来曲唑周期持续妊娠率/活产率高于程序化周期(aRR 1.11,95%CI 1.02-1.21),与自然周期相当(aRR 1.05,95%CI 0.96-1.14)。
  • 自然周期与程序化周期持续妊娠率/活产率相当(aRR 1.06,95%CI 0.99-1.13)。
  • 自然周期临床流产率低于程序化周期(aRR 0.62,95%CI 0.46-0.84);来曲唑与程序化周期、来曲唑与自然周期之间临床流产率无差异。
  • 排卵正常女性中来曲唑周期持续妊娠率/活产率高于程序化周期(aRR 1.16,95%CI 1.05-1.28)。
  • 排卵正常女性中,来曲唑周期(aRR 0.44,95%CI 0.22-0.87)和自然周期(aRR 0.59,95%CI 0.43-0.80)临床流产率均低于程序化周期;无排卵女性中来曲唑与程序化周期持续妊娠率/活产率相似(aRR 0.95,95%CI 0.79-1.13)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate and compare pregnancy outcomes between letrozole ovulation induction, natural, and programmed frozen-thawed embryo transfer (FET) cycles in a population based in the United States. DESIGN: Retrospective cohort study. SETTING: Single university-affiliated infertility practice. PATIENT(S): A total of 3,148 FET cycles consisting of patients aged ≤45 years transferring blastocysts that were created from autologous oocytes between January 2015 and July 2021. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The primary outcome was the ongoing pregnancy rate (OPR) or live birth rate (LBR). The secondary outcomes included clinical pregnancy and clinical loss rates (CLRs). RESULT(S): The OPR/LBR was higher among letrozole FETs than among programmed FETs (adjusted risk ratio [aRR] 1.11, 95% confidence interval [CI] 1.02-1.21) but comparable to natural FETs (aRR 1.05, 95% CI 0.96-1.14). The OPR/LBR was comparable between natural and programmed FETs (aRR 1.06, 95% CI 0.99-1.13). The CLR was lower in the natural FET group than in the programmed FET group (aRR 0.62, 95% CI 0.46-0.84). There were no differences in CLRs between letrozole and programmed FETs and between letrozole and natural FETs. Among ovulatory women, the OPR/LBR among letrozole FETs was higher than that among programmed FETs (aRR 1.16, 95% CI 1.05-1.28). The CLR among ovulatory women was significantly lower in both letrozole FETs (aRR 0.44, 95% CI 0.22-0.87) and natural FETs (aRR 0.59, 95% CI 0.43-0.80) than in programmed FETs. Among anovulatory women, the OPR/LBR in the letrozole FET group was similar to that in the programmed FET group (aRR 0.95, 95% CI 0.79-1.13). CONCLUSION(S): Letrozole and natural FET clinical outcomes were improved compared with programmed FET outcomes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Godiwala P, Makhijani R, Bartolucci A, et al. Pregnancy outcomes after frozen-thawed embryo transfer using letrozole ovulation induction, natural, or programmed cycles. Fertil Steril. 2022. PMID: 35863997. doi:10.1016/j.fertnstert.2022.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。